Variations and increase in use of statins across Europe: data from administrative databases.
作者信息
Walley Tom, Folino-Gallo Pietro, Schwabe Ulrich, van Ganse Eric
机构信息
Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool L69 3GF.
出版信息
BMJ. 2004 Feb 14;328(7436):385-6. doi: 10.1136/bmj.328.7436.385.
Abstract
摘要
相似文献
1
Variations and increase in use of statins across Europe: data from administrative databases.
BMJ. 2004 Feb 14;328(7436):385-6. doi: 10.1136/bmj.328.7436.385.
2
Trends in prescribing and utilization of statins and other lipid lowering drugs across Europe 1997-2003.
Br J Clin Pharmacol. 2005 Nov;60(5):543-51. doi: 10.1111/j.1365-2125.2005.02478.x.
3
Should statins be given routinely in all coronary patients?
Int J Cardiol. 2009 Jul 10;135(3):399-401. doi: 10.1016/j.ijcard.2008.05.001. Epub 2008 Jun 20.
4
Statins to reduce risk of depression.
J Am Coll Cardiol. 2004 Mar 17;43(6):1132; author reply 1132-3. doi: 10.1016/j.jacc.2003.12.029.
5
Statins for secondary stroke prevention in patients without known coronary heart disease: the jury is still out.
Cerebrovasc Dis. 2004;18(1):1-2. doi: 10.1159/000078600. Epub 2004 May 19.
6
Benefits of the statins: beyond cholesterol.
Harv Mens Health Watch. 2001 Aug;6(1):1-5.
7
Four out of ten patients are not taking statins regularly during the 12 months after an acute coronary event.
Eur J Prev Cardiol. 2012 Jun;19(3):349-57. doi: 10.1177/1741826711403069. Epub 2011 Mar 14.
8
Achieving lipid goals in Europe: how large is the treatment gap?
Expert Rev Cardiovasc Ther. 2004 May;2(3):431-49. doi: 10.1586/14779072.2.3.431.
9
Case selection for statins was similar in two Canadian provinces: BC and Ontario.
J Clin Epidemiol. 2007 Jan;60(1):73-8. doi: 10.1016/j.jclinepi.2006.04.007. Epub 2006 Sep 7.
10
High-density lipoprotein-dependent effects of statins on the risk of coronary heart disease deaths and events.
Int J Cardiol. 2011 Nov 3;152(3):377-9. doi: 10.1016/j.ijcard.2011.07.071. Epub 2011 Aug 17.
引用本文的文献
1
Statins and long-term risk of revision surgery after total hip arthroplasty in osteoarthritis: a multi-source data linkage study.
Front Pharmacol. 2025 Apr 15;16:1492200. doi: 10.3389/fphar.2025.1492200. eCollection 2025.
2
Statins Are Associated with Improved Survival of Patients with Gastric Cancer: A Systematic Review and Meta-Analysis.
Int J Clin Pract. 2022 May 17;2022:4938539. doi: 10.1155/2022/4938539. eCollection 2022.
3
Rosuvastatin alters the genetic composition of the human gut microbiome.
Sci Rep. 2020 Mar 25;10(1):5397. doi: 10.1038/s41598-020-62261-y.
4
Cross-sectional analysis of the prevalence and predictors of statin utilisation in Ireland with a focus on primary prevention of cardiovascular disease.
BMJ Open. 2018 Feb 8;8(2):e018524. doi: 10.1136/bmjopen-2017-018524.
5
Pre-diagnostic statin use, lymph node status and mortality in women with stages I-III breast cancer.
Br J Cancer. 2017 Aug 8;117(4):588-596. doi: 10.1038/bjc.2017.227. Epub 2017 Jul 18.
6
Residual cardiovascular risk in patients who received lipid-lowering treatment in a real-life setting: retrospective study.
Clinicoecon Outcomes Res. 2016 Oct 25;8:649-655. doi: 10.2147/CEOR.S107992. eCollection 2016.
7
Use of Generics-A Critical Cost Containment Measure for All Healthcare Professionals in Europe?
Pharmaceuticals (Basel). 2010 Aug 5;3(8):2470-2494. doi: 10.3390/ph3082470.
8
Epidemiology of coronary artery bypass grafting at the Hospital Beneficência Portuguesa, São Paulo.
Rev Bras Cir Cardiovasc. 2015 Jan-Mar;30(1):33-9. doi: 10.5935/1678-9741.20140062.
9
Statins: do they have a potential role in cancer prevention and modifying cancer-related outcomes?
Drugs. 2014 Oct;74(16):1841-1848. doi: 10.1007/s40265-014-0309-2.
10
Which statin worked best to achieve lipid level targets in a European registry? A post-hoc analysis of the EUROASPIRE III for coronary heart disease patients.
J Saudi Heart Assoc. 2014 Oct;26(4):183-91. doi: 10.1016/j.jsha.2014.04.005. Epub 2014 May 4.
本文引用的文献
1
EURO-MED-STAT: monitoring expenditure and utilization of medicinal products in the European Union countries: a public health approach.
Eur J Public Health. 2003 Sep;13(3 Suppl):95-100. doi: 10.1093/eurpub/13.suppl_1.95.
2
Age, sex and practice variations in the use of statins in general practice in England and Wales.
J Public Health Med. 2000 Sep;22(3):275-9. doi: 10.1093/pubmed/22.3.275.
3
Lack of adherence to lipid-lowering drug treatment. A comparison of utilization patterns in defined populations in Funen, Denmark and Bologna, Italy.
Br J Clin Pharmacol. 2000 May;49(5):463-71. doi: 10.1046/j.1365-2125.2000.00192.x.
Zotero 插件